Discover 2,440 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,440
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Boston MA, Hawthorne NY, Staten Island NY,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase 3, Recruiting
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
for
Biliary Tract Cancer
Location: Halifax, Providence RI, Hartford CT, New Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07221253
Phase 3, Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: Sparta NJ, Marlton NJ, Greenbelt MD, Richmond VA,
Sponsor: Eccogene
Sex: All
Age: 18 - 70+
Code: NCT07288138
Phase 2, Recruiting
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Location: Frederick MD, St Louis MO, Springfield MO,
Sponsor: Elephas
Sex: All
Age: 18+
Code: NCT07327489
Recruiting
A Phase 2 Study of MZE829 in Adults With APOL1 Kidney Disease
for
Proteinuric Kidney Disease
Location: Bloomfield CT, Laurelton NY, Maspeth NY, Jersey City NJ,
Sponsor: Maze Therapeutics
Sex: All
Age: 18 - 68
Code: NCT06830629
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
for
Advanced Solid Malignancies, Non-small Cell Lung Cancer (NSCLC),
Location: Baltimore MD, Fairfax VA, Toronto, San Antonio TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07223047
Phase 1, Phase 2, Recruiting
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
for
Type 2 Diabetes, Cortisol Excess
Location: Springfield MA, Albany NY, West Chester PA,
Sponsor: Sparrow Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07296484
Phase 2, Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
for
Gastrointestinal Neoplasms
Location: Boston MA, New Haven CT, Calgary, New Hyde Park NY,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT07218926
Phase 3, Recruiting
Ketorolac Effects on Post-operative Pain and Lumbar Fusion
for
Lumbar Spinal Fusion
Location: Towson MD
Sponsor: University of Maryland St. Joseph Medical Center
Sex: All
Age: 18 - 70+
Code: NCT06513208
Recruiting
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Valhalla NY, Philadelphia PA, Wilmington DE,
Sponsor: Children's Oncology Group
Sex: All
Age: 2 - 18
Code: NCT05711667
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
for
Untreated, Unresectable, or Metastatic Colorectal Cancer
Location: Shirley NY, Sherbrooke, Mineola NY, Lake Success NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221357
Phase 2, Phase 3, Recruiting
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
for
Glioblastoma
Location: Providence RI, Lebanon NH, Valhalla NY, Neptune City NJ,
Sponsor: GT Medical Technologies, Inc.
Sex: All
Age: 18+
Code: NCT07195591
Phase 3, Recruiting
Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy